Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Biol Cell ; 29(9): 1111-1124, 2018 05 01.
Article in English | MEDLINE | ID: mdl-29496966

ABSTRACT

C3G (Crk SH3 domain binding guanine nucleotide releasing factor) (Rap guanine nucleotide exchange factor 1), essential for mammalian embryonic development, is ubiquitously expressed and undergoes regulated nucleocytoplasmic exchange. Here we show that C3G localizes to SC35-positive nuclear speckles and regulates splicing activity. Reversible association of C3G with speckles was seen on inhibition of transcription and splicing. C3G shows partial colocalization with SC35 and is recruited to a chromatin and RNase-sensitive fraction of speckles. Its presence in speckles is dependent on intact cellular actin cytoskeleton and is lost on expression of the kinase Clk1. Rap1, a substrate of C3G, is also present in nuclear speckles, and inactivation of Rap signaling by expression of GFP-Rap1GAP alters speckle morphology and number. Enhanced association of C3G with speckles is seen on glycogen synthase kinase 3 beta inhibition or differentiation of C2C12 cells to myotubes. CRISPR/Cas9-mediated knockdown of C3G resulted in altered splicing activity of an artificial gene as well as endogenous CD44. C3G knockout clones of C2C12 as well as MDA-MB-231 cells showed reduced protein levels of several splicing factors compared with control cells. Our results identify C3G and Rap1 as novel components of nuclear speckles and a role for C3G in regulating cellular RNA splicing activity.


Subject(s)
Guanine Nucleotide-Releasing Factor 2/metabolism , Guanine Nucleotide-Releasing Factor 2/physiology , RNA Splicing/physiology , Animals , Cell Differentiation , Cell Line , Cell Line, Tumor , Cell Nucleus Structures/physiology , Guanine Nucleotide Exchange Factors/metabolism , Humans , Nuclear Proteins , Protein Binding , Protein Serine-Threonine Kinases , Protein-Tyrosine Kinases , RNA Processing, Post-Transcriptional/physiology , RNA, Messenger/metabolism , Serine-Arginine Splicing Factors/metabolism , Serine-Arginine Splicing Factors/physiology , Shelterin Complex , Signal Transduction , Spliceosomes , Telomere-Binding Proteins/metabolism
2.
Mol Cell Biochem ; 365(1-2): 323-32, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22382637

ABSTRACT

Lamins are the major structural components of the nucleus and mutations in the human lamin A gene cause a number of genetic diseases collectively termed laminopathies. At the cellular level, lamin A mutations cause aberrant nuclear morphology and defects in nuclear functions such as the response to DNA damage. We have investigated the mechanism of depletion of a key damage sensor, ATR (Ataxia-telangiectasia-mutated-and-Rad3-related) kinase, in HeLa cells expressing lamin A mutants or lamin A shRNA. The degradation of ATR kinase in these cells was through the proteasomal pathway as it was reversed by the proteasomal inhibitor MG132. Expression of lamin A mutants or shRNA led to transcriptional activation of three ubiquitin ligase components, namely, RNF123 (ring finger protein 123), HECW2 (HECT domain ligase W2) and the F-box protein FBXW10. Ectopic expression of RNF123, HECW2 or FBXW10 directly resulted in proteasomal degradation of ATR kinase and the ring domain of RNF123 was required for this degradation. However, these ligases did not alter the stability of DNA-dependent protein kinase, which is not depleted upon lamin misexpression. Although degradation of ATR kinase was reversed by MG132, it was not affected by the nuclear export inhibitor, leptomycin B, suggesting that ATR kinase is degraded within the nucleus. Our findings indicate that lamin misexpression can lead to deleterious effects on the stability of the key DNA damage sensor, ATR kinase by upregulation of specific components of the ubiquitination pathway.


Subject(s)
Cell Cycle Proteins/metabolism , Gene Expression , Lamin Type A/genetics , Protein Serine-Threonine Kinases/metabolism , Ubiquitin-Protein Ligases/metabolism , Up-Regulation , Ataxia Telangiectasia Mutated Proteins , Cell Nucleus/metabolism , F-Box Proteins/genetics , F-Box Proteins/metabolism , Gene Knockdown Techniques , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , HeLa Cells , Humans , Lamin Type A/metabolism , Leupeptins/pharmacology , Microscopy, Fluorescence , Mutagenesis, Site-Directed , Mutation, Missense , Proteasome Endopeptidase Complex/metabolism , Proteasome Inhibitors , Protein Denaturation , RNA Interference , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Ubiquitin-Protein Ligases/genetics
3.
J Cell Sci ; 119(Pt 13): 2704-14, 2006 Jul 01.
Article in English | MEDLINE | ID: mdl-16772334

ABSTRACT

A-type lamins are components of the nuclear lamina. Mutations in the gene encoding lamin A are associated with a range of highly degenerative diseases termed laminopathies. To evaluate sensitivity to DNA damage, GFP-tagged lamin A cDNAs with disease-causing mutations were expressed in HeLa cells. The inner nuclear membrane protein emerin was mislocalised upon expression of the muscular dystrophy mutants G232E, Q294P or R386K, which aberrantly assembled into nuclear aggregates, or upon expression of mutants causing progeria syndromes in vivo (lamin A del50, R471C, R527C and L530P). The ability of cells expressing these mutants to form DNA repair foci comprising phosphorylated H2AX in response to mild doses of cisplatin or UV irradiation was markedly diminished, unlike the nearly normal response of cells expressing wild-type GFP-lamin A or disease-causing H222P and R482L mutants. Interestingly, mutants that impaired the formation of DNA repair foci mislocalised ATR (for ;ataxia telangiectasia-mutated and Rad3-related') kinase, which is a key sensor in the response to DNA damage. Our results suggest that a subset of lamin A mutants might hinder the response of components of the DNA repair machinery to DNA damage by altering interactions with chromatin.


Subject(s)
DNA Repair-Deficiency Disorders/metabolism , DNA Repair , Lamin Type A/genetics , Lamin Type A/metabolism , Mutant Proteins/metabolism , Ataxia Telangiectasia Mutated Proteins , Cell Cycle Proteins/metabolism , Cisplatin/pharmacology , DNA Damage/drug effects , DNA Damage/radiation effects , HeLa Cells , Histones/metabolism , Humans , Membrane Proteins/metabolism , Nuclear Proteins , Progeria/metabolism , Protein Serine-Threonine Kinases/metabolism , Thymopoietins/metabolism , Tissue Distribution , Ultraviolet Rays
4.
J Cell Biol ; 159(5): 783-93, 2002 Dec 09.
Article in English | MEDLINE | ID: mdl-12473687

ABSTRACT

The A-type lamins have been observed to colocalize with RNA splicing factors in speckles within the nucleus, in addition to their typical distribution at the nuclear periphery. To understand the functions of lamin speckles, the effects of transcriptional inhibitors known to modify RNA splicing factor compartments (SFCs) were examined. Treatment of HeLa cells with alpha-amanitin or 5,6-dichlorobenzimidazole riboside (DRB) inhibited RNA polymerase II (pol II) transcription and led to the enlargement of lamin speckles as well as SFCs. Removal of the reversible inhibitor DRB resulted in the reactivation of transcription and a rapid, synchronous redistribution of lamins and splicing factors to normal-sized speckles, indicating a close association between lamin speckles and SFCs. Conversely, the expression of NH2-terminally modified lamin A or C in HeLa cells brought about a loss of lamin speckles, depletion of SFCs, and down-regulation of pol II transcription without affecting the peripheral lamina. Our results suggest a unique role for lamin speckles in the spatial organization of RNA splicing factors and pol II transcription in the nucleus.


Subject(s)
Lamin Type A/physiology , Lamin Type A/ultrastructure , Nuclear Proteins/analysis , RNA Polymerase II/metabolism , RNA Splicing , Transcription, Genetic , Amanitins/pharmacology , Antibodies, Monoclonal/metabolism , Cell Compartmentation , Cell Nucleus/chemistry , Cell Nucleus/enzymology , Cell Nucleus/metabolism , Dichlororibofuranosylbenzimidazole/pharmacology , Down-Regulation , HeLa Cells , Humans , Kinetics , Lamin Type A/genetics , Nucleic Acid Synthesis Inhibitors/pharmacology , RNA Polymerase II/antagonists & inhibitors , Recombinant Proteins/metabolism , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...